199 related articles for article (PubMed ID: 1725942)
1. Medical treatment of benign prostatic hyperplasia.
Schmidt JD
West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942
[No Abstract] [Full Text] [Related]
2. [Prostatic adenoma: new drugs, new surgical techniques].
Heinzl S
Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
[No Abstract] [Full Text] [Related]
3. Benign prostatic hyperplasia: drug and nondrug therapies.
Bruskewitz RC
Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
[TBL] [Abstract][Full Text] [Related]
4. Thoughts on finasteride for benign prostatic hyperplasia.
Anand A
Am Fam Physician; 1993 Sep; 48(4):582, 588. PubMed ID: 7691035
[No Abstract] [Full Text] [Related]
5. Finasteride for benign prostatic hyperplasia.
Hasinski S; Miller JL; Rose LI
Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
[TBL] [Abstract][Full Text] [Related]
6. Finasteride for benign prostatic hypertrophy.
Med Lett Drugs Ther; 1992 Sep; 34(878):83-4. PubMed ID: 1380630
[No Abstract] [Full Text] [Related]
7. New options for patients with benign prostatic hyperplasia.
Ellenberger B
CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
[No Abstract] [Full Text] [Related]
8. [5-alpha reductase inhibitor in prostatic adenoma?].
Heinzl S
Med Monatsschr Pharm; 1990 Dec; 13(12):382-4. PubMed ID: 1705307
[No Abstract] [Full Text] [Related]
9. [Drug treatment of benign prostatic hyperplasia].
Schmid HP
Praxis (Bern 1994); 1995 Sep; 84(39):1061-2. PubMed ID: 7481307
[No Abstract] [Full Text] [Related]
10. [The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
MMW Fortschr Med; 2003 Jul; 145(27-28):59. PubMed ID: 14587194
[No Abstract] [Full Text] [Related]
11. Is the prostate pill finally here?
Lange PH
N Engl J Med; 1992 Oct; 327(17):1234-6. PubMed ID: 1383817
[No Abstract] [Full Text] [Related]
12. Transurethral resection of the prostate: still the gold standard?
Ramsey EW
Can J Surg; 1993 Feb; 36(1):9-10. PubMed ID: 7680274
[No Abstract] [Full Text] [Related]
13. Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol.
Matzkin H; Chen J; Lewyshon O; Ayalon D; Braf Z
Horm Metab Res; 1992 Oct; 24(10):498-9. PubMed ID: 1281461
[No Abstract] [Full Text] [Related]
14. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group.
J Androl; 1991; 12(6):372-5. PubMed ID: 1722792
[TBL] [Abstract][Full Text] [Related]
15. Finasteride: a 5 alpha-reductase inhibitor.
Steiner JF
Clin Pharm; 1993 Jan; 12(1):15-23. PubMed ID: 7679063
[TBL] [Abstract][Full Text] [Related]
16. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia.
McConnell JD
Urol Clin North Am; 1990 Aug; 17(3):661-70. PubMed ID: 1695786
[TBL] [Abstract][Full Text] [Related]
17. What is the best medical treatment for benign prostate hyperplasia?
Evans MF; Frank J
Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
[No Abstract] [Full Text] [Related]
18. Pharmacological treatment of benign prostatic hyperplasia, current options and future perspectives.
Hansen BJ
Scand J Urol Nephrol Suppl; 1996; 180():1-55. PubMed ID: 8936639
[No Abstract] [Full Text] [Related]
19. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
20. Medical management of benign prostatic hyperplasia--are two drugs better than one?
Vaughan ED
N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
